dr. graff on current treatments in esr1-mutant breast cancer
Published 5 years ago • 342 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
1:12
dr. graff underscores unmet needs in esr1-mutated breast cancer
-
0:52
dr. graff on future research with immunotherapy in breast cancer
-
2:32
dr. goetz on treatment challenges for esr1-mutant breast cancer
-
1:18
dr. graff on extended adjuvant therapy in early-stage hr breast cancer
-
0:52
dr. graff on genomic risk prediction in hr /her2- breast cancer
-
1:12
dr. fuqua on esr1 mutations in primary breast cancer
-
1:29
dr. cristofanilli on lasofoxifene in esr1-mutant breast cancer
-
1:47
dr. goncalves describes research involving the esr1 mutation in breast cancer
-
2:06
elaine 1: esr1 mutations in ctdna from er /her2- mbc treated with lasofoxifene or fulvestrant
-
4:48
breast cancer breakthroughs: the importance of esr1 mutations in metastatic breast cancer
-
0:59
dr. graff discusses optimal dosing of tamoxifen in breast cancer
-
37:03
esr1 mutations in metastatic breast cancer: should i get tested?
-
1:19
dr. graff on tamoxifen de-escalation in breast cancer
-
1:26
dr. rugo on rationale for the elaine study in esr1-mutated er /her2- breast cancer
-
0:48
dr. graff discusses the treatment of prostate cancer
-
25:28
episode 2: oral serds in er breast cancer: treatment selection and beyond
-
9:44
navigating er metastatic breast cancer: explore a patient case
-
19:22
spotlight session: "transcriptional reprogramming, esr1 mutations, and novel targets and treatment"
-
1:02:48
expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more